Covishield vaccine

'I got Covishield from India': President of the 76th UN General Assembly Abdulla Shahid

India has exported over 66 million vaccine doses to nearly 100 countries through grants, commercial shipments and the COVAX facility.

published on : 2nd October 2021

Delhi HC seeks Centre's stand on plea seeking Covaxin instead of Covishield as second dose

As per the doctor's advice and the prior complications of the Covishield vaccine, the petitioner was reportedly advised to take Covaxin as the second dose.

published on : 27th September 2021

Will be able to manufacture, supply 10 crore Covishield doses in June: Serum Institute to Centre 

India is currently using made-in-India vaccines -- Covishield manufactured by SII and Covaxin of Bharat Biotech -- in its COVID-19 immunisation programme.

published on : 30th May 2021

HC seeks Uddhav government's reply on plea seeking Z-plus security for Adar Poonawalla

The petitioner will have to bear in mind while arguing this matter that "India has a good reputation and such proceedings will have an international impact", the HC said.

published on : 27th May 2021

SII endorses receiving Rs 1,732 cr for 11 crore doses of Covishield vaccine

The company's response came after the Health Ministry in a statement refuted allegations that it has not placed any fresh orders for the Covishield vaccine with SII.

published on : 3rd May 2021

One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet study

The drop in infection at least 21 days after the first dose for Pfizer is 69 per cent and for AstraZeneca 60 per cent, according to the study.

published on : 28th April 2021

Centre asks states to increase gap between Covishield doses

Scientific evidence from some countries shows that while the vaccine is about 60-65 % effective at a gap of four weeks, it can be up to 90 % effective when given at an interval of 12 weeks.

published on : 22nd March 2021